20 likes | 130 Views
Risk for all vascular events across HDL-c quartiles, with or without lipid-lowering therapy. No lipid-lowering medication. 2. Lipid-lowering medication. 1. HR. 0,5. 1. 2. 3. 4. Van de Woestijne et al ., JACC 2013.
E N D
Risk for all vascular events across HDL-c quartiles, with or without lipid-lowering therapy No lipid-lowering medication 2 Lipid-lowering medication 1 HR 0,5 1 2 3 4 Van de Woestijne et al., JACC 2013
Risk for all vascular events across HDL-c quartiles, with/without intensive lipid-lowering therapy No intensive lipid-lowering therapy 2 Intensive lipid- lowering therapy 1 HR 0,5 1 2 3 4 Van de Woestijne et al., JACC 2013